467 results on '"Ruozi, Barbara"'
Search Results
2. Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor
3. C-end rule peptide-guided niosomes for prostate cancer cell targeting
4. Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
5. Quantitative comparison of the protein corona of nanoparticles with different matrices
6. Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology
7. Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease
8. Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence
9. Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
10. Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines
11. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery
12. “Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury
13. Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136]
14. Supplementary Table 1 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
15. Supplementary Figure 3 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
16. Supplementary Figure Legend from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
17. Supplementary Methods from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
18. Supplementary Figure 2 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
19. Supplementary Figure 1 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
20. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy
21. Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides
22. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization
23. Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles
24. Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers
25. The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system
26. Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems
27. Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model
28. I17 Sustained benefits of brain-permeable cholesterol-loaded nanoparticles in zQ175DN mouse model
29. Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
30. Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
31. Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
32. Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release
33. Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport
34. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution
35. Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders
36. PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury
37. Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles.
38. Tunneling Nanotubes: A New Target for Nanomedicine?
39. Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
40. Amphiphilic ion pairs of tobramycin with lipoamino acids
41. Tween® Preserves Enzyme Activity and Stability in PLGA Nanoparticles
42. Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations
43. Microfluidic Technology for the Production of Hybrid Nanomedicines
44. I07 A new generation of brain-targeted nanoparticles for cholesterol delivery in huntington’s disease: kinetics, drug release and behavioral effects in mouse models
45. Nanomedicines for brain diseases: where we are and where we are going
46. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity
47. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter
48. Microfluidic technology for the production of hybrid nanomedicines
49. Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation
50. Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.